Medprin Regenerative Medical Technologies Co Ltd Class A 301033
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥39.92
- Day Range
- ¥40.03–42.56
- 52-Week Range
- ¥22.37–47.95
- Bid/Ask
- ¥42.48 / ¥42.49
- Market Cap
- ¥2.81 Bil
- Volume/Avg
- 1.0 Mil / 537,163
Key Statistics
- Price/Earnings (Normalized)
- 47.52
- Price/Sales
- 9.85
- Dividend Yield (Trailing)
- 1.00%
- Dividend Yield (Forward)
- 1.00%
- Total Yield
- 1.00%
Company Profile
Medprin Regenerative Medical Technologies Co Ltd is engaged in the development and manufacturing of high-performance implanted medical devices.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 278
- Website
- https://www.medprin.com
Comparables
Valuation
|
Metric
|
301033
|
688161
|
688016
|
|---|---|---|---|
Price/Earnings (Normalized) | 47.52 | 82.29 | 17.66 |
Price/Book Value | 4.14 | 2.37 | 2.73 |
Price/Sales | 9.85 | 7.57 | 7.64 |
Price/Cash Flow | 28.33 | 56.15 | 15.28 |
Price/Earnings
301033
688161
688016
Financial Strength
|
Metric
|
301033
|
688161
|
688016
|
|---|---|---|---|
Quick Ratio | 4.60 | 2.16 | 8.91 |
Current Ratio | 6.54 | 4.05 | 9.53 |
Interest Coverage | 40.89 | 91.82 | 413.50 |
Quick Ratio
301033
688161
688016
Profitability
|
Metric
|
301033
|
688161
|
688016
|
|---|---|---|---|
Return on Assets (Normalized) | 7.51% | 1.75% | 16.12% |
Return on Equity (Normalized) | 8.88% | 2.31% | 18.19% |
Return on Invested Capital (Normalized) | 8.37% | 1.76% | 17.54% |
Return on Assets
301033
688161
688016
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Qwfhkrsk | Nkpwfl | $196.1 Bil | |||
| Stryker Corp
SYK
| Hqbvfzggs | Wzty | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Xnckcvj | Zzdqskg | $122.3 Bil | |||
| Medtronic PLC
MDT
| Kbmvttxy | Bkbgpr | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Pyvfgyfnxb | Yjhygxr | $39.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Njm | Xkkh | $29.3 Bil | |||
| DexCom Inc
DXCM
| Ybylkslmsb | Gxwfs | $27.1 Bil | |||
| Steris PLC
STE
| Ynchqqd | Vbrjtd | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Pfmvhfblp | Tzf | $21.9 Bil | |||
| Insulet Corp
PODD
| Fjlggzss | Mfscx | $16.5 Bil |
United States